You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
Mallinckrodt
Johnson and Johnson
McKesson
McKinsey

Last Updated: June 1, 2020

DrugPatentWatch Database Preview

Patent: 6,861,517

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,861,517
Title: Nucleic acid fragments, recombinant vector containing the same and method for promoting the expression of structural gene by using the same
Abstract:Nucleic acid fragments having activities to prominently promote expression of structural genes located downstream thereof are disclosed. The nucleic acid fragment according to the present invention is an isolated nucleic acid fragment having the nucleotide sequence shown in SEQ ID NO: 1 in Sequence Listing or an isolated nucleic acid fragment (excluding the nucleic acid having the nucleotide sequence shown in SEQ ID NO: 3 in Sequence Listing) having the same nucleotide sequence as shown in SEQ ID NO: 1 except that one or a plurality of nucleotides are substituted or deleted, or except that one or a plurality of nucleotides are inserted or added, which has an activity to promote expression of a structural gene located downstream of said nucleic acid fragment.
Inventor(s): Ueki; Jun (Sizuoka, JP)
Assignee: Japan Tobacco Inc. (Tokyo, JP)
Application Number:09/600,602
Patent Claims:see list of patent claims

Details for Patent 6,861,517

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Japan Tobacco Inc. (Tokyo, JP) 2018-11-19 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Start Trial Japan Tobacco Inc. (Tokyo, JP) 2018-11-19 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Start Trial Japan Tobacco Inc. (Tokyo, JP) 2018-11-19 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Medtronic
Colorcon
Mallinckrodt
Dow
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.